Evidence map›Paper›PMID 35070358›Full record

ReviewFuture science OA2022

Autologous conditioned serum applications in the treatment of musculoskeletal diseases: a narrative review.

Seyed Ahmad Raeissadat, Seyed Mansoor Rayegani, Nafisseh Jafarian, Mina Heidari

Open access · goldAbstract readReview
In one paragraph

Review in Future science OA, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Regenerative Medicine: The Next Generation of Autologous Blood Formulations.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Seyed Ahmad RaeissadatPhysical Medicine & Rehabilitation Department, Clinical Research Development Center of Shahid Modarres Educational Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, District 2, Sa'adatabad Boulevard, 19987 34383, Tehran, Iran.ORCID https://orcid.org/0000-0003-1512-0921
Seyed Mansoor RayeganiPhysical Medicine & Rehabilitation Department, Clinical Research Development Center of Shahid Modarres Educational Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, District 2, Sa'adatabad Boulevard, 19987 34383, Tehran, Iran.ORCID https://orcid.org/0000-0003-3819-4333
Nafisseh JafarianPhysical Medicine & Rehabilitation Department, Clinical Research Development Center of Shahid Modarres Educational Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, District 2, Sa'adatabad Boulevard, 19987 34383, Tehran, Iran.ORCID https://orcid.org/0000-0002-5250-6447
Mina HeidariPhysical Medicine & Rehabilitation Department, Clinical Research Development Center of Shahid Modarres Educational Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, District 2, Sa'adatabad Boulevard, 19987 34383, Tehran, Iran.ORCID https://orcid.org/0000-0003-2603-6303
Shahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimAutologous conditioned serum has been studied as a treatment option in musculoskeletal disorders and resulted in varying outcomes. This study aims to pool the current data on this matter. MATERIALS &

methodsMajor databases were searched for the topics, and after screening the results, the final 21 papers (level of evidence I or II) were included. RESULTS &

conclusionThis study showed a major focus of the literature on the effectiveness of autologous conditioned serum in osteoarthritis, in which there is much high-quality evidence suggesting its safety and efficacy. Also, some of the available experiments are assessing its application in tendinopathies and radiculopathies which, despite positive results, recommend further evaluations on this topic.

Indexed as

autologous conditioned serumInterleukin-1 receptor antagonist proteinliterature reviewmusculoskeletal diseasesorthokineosteoarthritis

Identifiers

PMID35070358
PMCPMC8765110
OpenAlexW4205570817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.